热门资讯> 正文
Alumis上市首日较IPO价格下跌22%
2024-06-29 01:37
- Clinical-stage biopharmaceutical company Alumis (NASDAQ:ALMS) is having a rough day on its first day of trading with shares trading well below its IPO price of $16/share.
- As of 130p ET, shares were trading at $12.50, an almost 22% decline from its IPO price.
- Although the IPO was priced at $16, when the stock began trading shortly after 1230p, it opened at $13.48.
More on Alumis Inc.
- Alumis' $100 Million IPO: Promising Psoriasis Treatment Results
- Alumis prices IPO at $16 per share
- Immunology drug developer Alumis files for $100M IPO
- Financial information for Alumis Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
